Welcome to WeiKu.com Sign In | Join Free
- My WeiKu
My WeiKu
- |
- Buy Offers
- |
- Suppliers
- |
- Products
Detail of 61-33-6
- Product Name:4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-
- CAS No:61-33-6
- Molecular Formula:C16H18 N2 O4 S
- Molecular Structure:
![CAS NO:61-33-6 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)- Molecular Structure](http://www.lookchem.com/300w/2010/0623/61-33-6.jpg "CAS NO:61-33-6 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)- Molecular Structure")
- Synonyms:4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)- (8CI);4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2S,5R,6R)- (9CI);4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2a,5a,6b)]-; Penicillin G (6CI);(5R,6R)-Benzylpenicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin;Benzylpenicillin G; Benzylpenicillinic acid; Cilloral; Cilopen; Crysticillin300 AS; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillinII; Gelacillin; Liquacillin; NSC 193396; Penicillin, (phenylmethyl)-;Penicillinic acid, (phenylmethyl)-; Pfizerpen; Pharmacillin;Phenylacetamidopenicillanic acid; Phenylacetyl-6-aminopenicillanic acid;Pradupen; Specilline G; Ursopen
- EINECS:200-506-3
- Molecular Weight:334.42
- Safety:Poison by ingestion, intravenous, intracerebral, intraspinal, subcutaneous, and possibly other routes. Human (child) systemic effects by parenteral route: changes in cochlear (inner ear) structure or function, convulsions, and dyspnea. Questionable carcinogen with experimental tumorigenic data. Mutation data reported. When heated to decomposition it emits very toxic fumes of NOx and SOx. See other penicillin entries.
Other Products
- benzyl (2S,5R,6R)-6-formamido-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate(53628-26-5)
- sodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[2-[(2-oxochromene-3-carbonyl)amino]-2-phenyl-acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate(67609-13-6)
- (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(3-phenoxypropanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid(1752-26-7)
- (2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (1R,4S)-3,3-dimethyl-2,2,6-trioxo-2$l^{6}-thiabicyclo[3.2.0]heptane-4-carboxylic acid(94935-63-4)
- Benzeneacetamide,R-amino-N-[(2S,5R,6R)-3,- 3-dimethyl-7-oxo-2-(1H-tetrazol-5-yl)-4- thia-1-azabicyclo[3.2.0]hept-6-yl]-4- hydroxy- (57089-17-5)
- sodium (2S,5R,6R)-6-[[2-[[2-[4-(2-acetamidopropanoylamino)phenyl]-4-oxo-3H-pyrimidine-5-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate(79033-91-3)
- (2S,5R,6R)-6-[(4-benzyl-5-methyl-oxolane-2-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid(61834-12-6)
- (2S,5R,6R)-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-[(2-amino-2-phenyl-acetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate(77442-45-6)
- N-benzyl-2-phenyl-ethanamine; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid(751-84-8)
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-, (4-nitrophenyl)methylester, 4-oxide, (2S,5R,6R)- (9CI)(29707-62-8)
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[(1,3-dioxo-3-phenoxy-2-phenylpropyl)amino]-3,3-dimethyl-7-oxo-,(2S,5R,6R)-(27025-49-6)
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3,3-dimethyl-7-oxo-,(2S,5R,6R)-(26774-90-3)
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-bromo-3,3-dimethyl-7-oxo-, (2S,5R,6R)-(26631-90-3)
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[[3-[(2,3-dihydro-1H-inden-5-yl)oxy]-1,3-dioxo-2-phenylpropyl]amino]-3,3-dimethyl-7-oxo-,sodium salt (1:1), (2S,5R,6R)-(26605-69-6)
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[[[(2S)-2-amino-2-carboxyethyl]thio]- acetyl]amino]-3,3-dimethyl-7-oxo-,(2S,5R,- 6R)- (56448-19-2)
- N,N-diethylethanamine; 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid(30154-78-0)
- D-Streptamine,O-2-deoxy-2-(methylamino)- R-L-glucopyranosyl-(1f2)-O-5-deoxy-3-C- (hydroxymethyl)-R-L-lyxofuranosyl-(1f4)-N,- N'-bis(aminoiminomethyl)-,mixt. with 2-(diethylamino)ethyl 4-aminobenzoate mono[(2S,5R,6R)-3,3-dimethyl-7-oxo-6- [(phenylacetyl)amino]-4-thia-1-azabicyclo- [3.2.0]heptane-2-carboxylate] (8017-41-2)
- 2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-[(2-amino-2-phenyl-acetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; 2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate(98445-47-7)
- Cochliodinone(56489-12-4)
- s-Triazine,hexahydro-1,3,5-tris(2,2,3-trichloropropionyl)- (8CI)(30805-20-0)
Properties
- Crystals.
TOXICITY
1. dnr-esc 20 µL/disc
MUREAV Mutation Research. 97 (1982),1. 2. dnr-bcs 100 µL/plate
MUREAV Mutation Research. 97 (1982),1. 3. mmo-omi 12 µg/L
ARMKA7 Archiv fuer Mikrobiologie. 81 (1972),1. 4. oms-omi 20 µg/L
AMACCQ Antimicrobial Agents and Chemotherapy. 17 (1980),572. 5. par-chd TDLo:15,000 units/kg:NOSE,CNS,PUL
BJCAAI British Journal of Cancer. 17 (1963),100. 6. orl-rat LD50:8 g/kg
ANTCAO Antibiotics and Chemotherapy. 12 (1962),249. 7. unk-rat LD50:9 g/kg
ANTBAL Antibiotiki. 23 (1978),317. 8. orl-mus LD50:>5 g/kg AACHAX -,619,67
9. ipr-mus LD50:3500 mg/kg AACHAX -,619,67
10. ivn-mus LD50:329 mg/kg
BCPCA6 Biochemical Pharmacology. 16 (1967),1365. 11. ice-mus LD50:5700 µg/kg
JLCMAK Journal of Laboratory and Clinical Medicine. 34 (1949),126. 12. unk-mus LD50:7800 mg/kg
ANTBAL Antibiotiki. 23 (1978),317. 13. ice-rbt LD50:1118 µg/kg
JLCMAK Journal of Laboratory and Clinical Medicine. 34 (1949),126. 14. isp-dog LD50:4940 µg/kg
JLCMAK Journal of Laboratory and Clinical Medicine. 34 (1949),126. 15. ice-rbt LD50:653 µg/kg
JLCMAK Journal of Laboratory and Clinical Medicine. 34 (1949),126. 16. orl-ham LD50:24 mg/kg
TXAPA9 Toxicology and Applied Pharmacology. 14 (1969),510. 17. scu-ham LD50:96 mg/kg
TXAPA9 Toxicology and Applied Pharmacology. 14 (1969),510.
